期刊文献+

新诊断2型糖尿病患者血浆纤维蛋白原、CPR水平与颈动脉内膜—中膜厚度的关系 被引量:1

暂未订购
导出
摘要 目的探讨2型糖尿病(T2DM)患者血浆纤维蛋白原(Fib)、C反应蛋白(CPR)水平与颈动脉内膜—中膜厚度(CIMT)的关系。方法根据CIMT将62例新诊断T2DM患者分为CIMT增厚组、正常组,检测并比较其血浆Fib、CPR及血脂水平。结果与CIMT正常组比较,增厚组血浆Fib、CPR升高(P<0.05或<0.01),血脂水平相似。结论 T2DM伴CIMT增厚患者的血浆Fib、CPR升高,提示炎症可能促进T2DM患者动脉粥样硬化形成。
作者 刘辉
机构地区 洛阳市中心医院
出处 《山东医药》 CAS 北大核心 2010年第37期44-44,共1页 Shandong Medical Journal
  • 相关文献

参考文献4

  • 1McBane RD 2nd,Hardison RM,Sobel BE,BARI 2D Study Group.Comparison of plasminogen activator inhibitor-1,tissue type plasminogen activator antigen,fibrinogen,and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease[J].Am J Cardiol,2010,105(1):17-24.
  • 2Becker RC,Cannon CP,Bovill EG,et al.Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction[J].Am J Cardiol,1996,78(2):142-147.
  • 3Bots ML,Hoes AW,Koudstaal PJ,et al.Common carotid intima-media thickness and risk of stroke and myocardial infarction:the rotterdam study[J].Circulation,1997,96(5):1432-1437.
  • 4Nguyen XM,Lane J,Smith BR,et al.Changes in inflammatory biomarkers across weight classes in a representative US population:a link between obesity and inflammation[J].J Gastrointest Surg,2009,13(7):1205-1212.

同被引文献12

  • 1Norata GD, Marchesi P, Pulakazhi Venu VK, et al. Deficiency of the long pentraxin grX3 promotes vascular inflammation and athero- sclerosis [ J ]. Circulation, 2009,120 ( 8 ) :699-708.
  • 2Suliman ME, Yilmaz MI, Carrero J J, et al. Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease[ J]. Clin J Am Soc Nephrol, 2008,3(4) :976-985.
  • 3Riccioni G, DOrazio N, Palumbo N, et al. Relationship between plasma antioxidant concentrations and carotid intima-media thick- ness: the Asymptomatic Carotid Atherosclerotic Disease In Manfre- donia Study[J]. Eur J Cardiovasc Prey Rehabil, 2009,16 (3) :351 - 357.
  • 4Norata GD, Garlanda C, Catapano AL. The long pentraxin PTX3 : a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases [ J ]. Trends Cardiovasc Med, 2010,20 (2) : 35-40.
  • 5Katakami N, Kaneto H, Sakamoto F, et al. Plasma pentraxin 3 levels are associated with carotid IMT in type 1 diabetic patients [J]. Diabetes Res Clin Pract, 2013,99(2).:185-191.
  • 6Stolz E, Kaps M, Kern A, et al. Transcranial color-coded duplex sonography of intracranial veins and sinuses in adults[J]. Stroke, 1999,30(5 ) : 1070-1075.
  • 7Nagai Y, Metter EJ, Earley CJ, et al. Increased carotid artery inti- malmedial thickness in asymptomatic older suhjects with exercise- induced myocardial ischemia [ J ]. Circulation, 1998,98 ( 15 ) : 1504-1509.
  • 8Lee DH, Jeon HK, You JH, et al. Pentraxin 3 as a novel marker predicting congestive heart failure in subjects with acute coronary syndrome[J]. Korean Circ J, 2010,40(8) :370-376.
  • 9Norata GD, Marchesi P, Pirillo A, et al. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipo- proteins in endothelial cells [ J]. Arterioscler Thromb Vasc Biol, 2008,28 ( 5 ) :925-931.
  • 10Rolph MS, Zimmer S, Bottazzi B, et al. Production of the long pentraxin FTX3 in advanced atherosclerotic plaques [ J]. Arterio- scler Thromb Vasc Biol, 2002,22(5 ) : 10-14.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部